Skip to main content
. 2024 Apr 6;14:37. doi: 10.1186/s13550-024-01101-w

Fig. 2.

Fig. 2

[177Lu]Lu-PP-F11N and SSTR2 imaging in all patients. [177Lu]Lu-PP-F11N SPECT maximum intensity projection (MIP) of patient 1–8 at 24 h p.i. without (left) and with (middle) Entresto® premedication. MIP of the corresponding SST2R PET/CT for each patient (right). Green arrows: MTC metastases, visible in [177Lu]Lu-PP-F11N scintigraphy. Red arrows: MTC metastases only visible in SST2R PET/CT in a single patient (only two of multiple metastases labelled). Blue arrows: urine contamination. Orange arrowheads: physiological stomach uptake. Furthermore, uptake in kidneys, bowels and urinary bladder is visible in all patients